Compare Oscar Health Inc (OSCR) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance

Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.

The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.

TLH trades at $98.13, down 0.56% over 24 hours, with technical indicators signaling a bearish trend. The stock faces resistance near $99 and support at $97. Recent dividend payments of $0.41 and $0.36 in mid-2026 provide income, but key financial ratios like P/E and ROE are unavailable, limiting fundamental clarity. Broader market volatility, driven by Federal Reserve uncertainty and geopolitical tensions, adds to the cautious backdrop.

The outlook for TLH remains guarded due to weak technical momentum and lack of visible fundamental strength. Investment opportunity hinges on improved earnings visibility and stabilization above key support. Risks include macroeconomic pressures and absence of current financial metrics, warranting careful monitoring for signs of operational improvement or further deterioration.